# Sculptra Aesthetic Post-Approval Study

> **NCT02425943** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 867 (actual)

## Conditions studied

- Nasolabial Fold Contour Deficiencies
- Wrinkles

## Interventions

- **DEVICE:** injectable poly-L-lactic acid Sculptra Aesthetic

## Key facts

- **NCT ID:** NCT02425943
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-21
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-05-28
- **Target enrollment:** 867 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02425943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02425943, "Sculptra Aesthetic Post-Approval Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02425943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*